Rejuvenation with PRF
Phase 2
- Conditions
- face aging.
- Registration Number
- IRCT20220218054054N1
- Lead Sponsor
- Shiraz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 16
Inclusion Criteria
Any adult over 30 with facial wrinkles
Exclusion Criteria
History of anticoagulant Administration such as warfarin and ASA
History of immunomodulatory medications
History of a medical problem such as connective tissue disorders
Pregnancy
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Skin facial aging. Timepoint: Prior and 12 weeks after PRF injection. Method of measurement: visioface device.
- Secondary Outcome Measures
Name Time Method